These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35197461)

  • 1. Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection.
    Pekayvaz K; Leunig A; Kaiser R; Joppich M; Brambs S; Janjic A; Popp O; Nixdorf D; Fumagalli V; Schmidt N; Polewka V; Anjum A; Knottenberg V; Eivers L; Wange LE; Gold C; Kirchner M; Muenchhoff M; Hellmuth JC; Scherer C; Rubio-Acero R; Eser T; Deák F; Puchinger K; Kuhl N; Linder A; Saar K; Tomas L; Schulz C; Wieser A; Enard W; Kroidl I; Geldmacher C; von Bergwelt-Baildon M; Keppler OT; Munschauer M; Iannacone M; Zimmer R; Mertins P; Hubner N; Hoelscher M; Massberg S; Stark K; Nicolai L
    Nat Commun; 2022 Feb; 13(1):1018. PubMed ID: 35197461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
    Cheemarla NR; Watkins TA; Mihaylova VT; Wang B; Zhao D; Wang G; Landry ML; Foxman EF
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34128960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.
    Lindeboom RGH; Worlock KB; Dratva LM; Yoshida M; Scobie D; Wagstaffe HR; Richardson L; Wilbrey-Clark A; Barnes JL; Kretschmer L; Polanski K; Allen-Hyttinen J; Mehta P; Sumanaweera D; Boccacino JM; Sungnak W; Elmentaite R; Huang N; Mamanova L; Kapuge R; Bolt L; Prigmore E; Killingley B; Kalinova M; Mayer M; Boyers A; Mann A; Swadling L; Woodall MNJ; Ellis S; Smith CM; Teixeira VH; Janes SM; Chambers RC; Haniffa M; Catchpole A; Heyderman R; Noursadeghi M; Chain B; Mayer A; Meyer KB; Chiu C; Nikolić MZ; Teichmann SA
    Nature; 2024 Jul; 631(8019):189-198. PubMed ID: 38898278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local and systemic responses to SARS-CoV-2 infection in children and adults.
    Yoshida M; Worlock KB; Huang N; Lindeboom RGH; Butler CR; Kumasaka N; Dominguez Conde C; Mamanova L; Bolt L; Richardson L; Polanski K; Madissoon E; Barnes JL; Allen-Hyttinen J; Kilich E; Jones BC; de Wilton A; Wilbrey-Clark A; Sungnak W; Pett JP; Weller J; Prigmore E; Yung H; Mehta P; Saleh A; Saigal A; Chu V; Cohen JM; Cane C; Iordanidou A; Shibuya S; Reuschl AK; Herczeg IT; Argento AC; Wunderink RG; Smith SB; Poor TA; Gao CA; Dematte JE; ; Reynolds G; Haniffa M; Bowyer GS; Coates M; Clatworthy MR; Calero-Nieto FJ; Göttgens B; O'Callaghan C; Sebire NJ; Jolly C; De Coppi P; Smith CM; Misharin AV; Janes SM; Teichmann SA; Nikolić MZ; Meyer KB
    Nature; 2022 Feb; 602(7896):321-327. PubMed ID: 34937051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2.
    Melgaço JG; Azamor T; Silva AMV; Linhares JHR; Dos Santos TP; Mendes YS; de Lima SMB; Fernandes CB; da Silva J; de Souza AF; Tubarão LN; Brito E Cunha D; Pereira TBS; Menezes CEL; Miranda MD; Matos AR; Caetano BC; Martins JSCC; Calvo TL; Rodrigues NF; Sacramento CQ; Siqueira MM; Moraes MO; Missailidis S; Neves PCC; Ano Bom APD
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
    Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
    Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.
    Aguilar-Jiménez W; Flórez-Álvarez L; Rincón DS; Marín-Palma D; Sánchez-Martínez A; Martínez J; Zapata MI; Loaiza JD; Cárdenas C; Guzmán F; Velilla PA; Taborda NA; Zapata W; Hernández JC; Díaz FJ; Rugeles MT
    Biomedica; 2021 Oct; 41(Sp. 2):86-102. PubMed ID: 34669281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients.
    Wang X; Bai H; Ma J; Qin H; Zeng Q; Hu F; Jiang T; Mao W; Zhao Y; Chen X; Qi X; Li M; Xu J; Hao J; Wang Y; Ding X; Liu Y; Huang T; Fang C; Ge C; Li D; Hu K; Ren X; Zhang B; Zhang B; Shi B; Zhang C
    Front Immunol; 2022; 13():812514. PubMed ID: 35281000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence.
    La Sala L; Gandini S; Bruno A; Allevi R; Gallazzi M; Senesi P; Palano MT; Meregalli P; Longhi E; Sommese C; Luzi L; Trabucchi E
    Front Immunol; 2022; 13():798813. PubMed ID: 35237261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
    Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
    Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes.
    Uranga-Murillo I; Morte E; Hidalgo S; Pesini C; García-Mulero S; Sierra JL; Santiago L; Arias M; De Miguel D; Encabo-Berzosa MDM; Gracia-Tello B; Sanz-Pamplona R; Martinez-Lostao L; Galvez EM; Paño-Pardo JR; Ramirez-Labrada A; Pardo J
    Theranostics; 2022; 12(1):290-306. PubMed ID: 34987646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term infection of SARS-CoV-2 changed the body's immune status.
    Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
    Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic meta-analysis of immune signatures in patients with COVID-19.
    Liu K; Yang T; Peng XF; Lv SM; Ye XL; Zhao TS; Li JC; Shao ZJ; Lu QB; Li JY; Liu W
    Rev Med Virol; 2021 Jul; 31(4):e2195. PubMed ID: 34260780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.
    Graham JB; Swarts JL; Leist SR; Schäfer A; Menachery VD; Gralinski LE; Jeng S; Miller DR; Mooney MA; McWeeney SK; Ferris MT; Pardo-Manuel de Villena F; Heise MT; Baric RS; Lund JM
    PLoS Pathog; 2021 Jan; 17(1):e1009287. PubMed ID: 33513210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.
    Di Vito C; Calcaterra F; Coianiz N; Terzoli S; Voza A; Mikulak J; Della Bella S; Mavilio D
    Front Immunol; 2022; 13():888248. PubMed ID: 35844604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.